Figure 5.
Chromatogram of radioactive metabolites derived from 3H-ropivacaine in the (A) liver, (B) serum, and (C) urine.
Radioactive substances which were extracted from the liver, serum, and urine at 1 hr (□) or 24 hr (▪) after injection with 0.5% 3H-ropivacaine into the right palatal mucosa proximal to the first molar, were separated by thin layer chromatography (TLC). The TLC plate was Silicagel 60F254® (Merck, Germany). The area from the lower end of the plate to the solvent front was divided into 1 to 9 zones. A spot of ropivacaine on the plate was confirmed with UV lamp (253.7 nm). Authentic ropivacaine was detected in zone No. 5. Ropivacaine or the metabolite in each silica gel zone was scratched from the plate and 3H-radioactivity in the zone was measured with the liquid scintillation counter. The radioactivity in each zone as a percentage of the total radioactivity on the TLC plate was calculated.
Amounts of 3H-radioactivity measured in zone No. 5 after 1 hr were 23.0%, and more radioactivity was detected in zones No. 3 and No. 4 in the liver (No. 3 vs No. 5: p<0.01, No. 4 vs No. 5: p<0.01), 67.3% in the serum (No. 5 vs No. 6: p<0.01) and 63.0% in the urine (No. 5 vs No. 6: p<0.01). After 24 hr, more than 80% of the total radioactivity was detected in zones except zone No. 5.
Data are mean ± SD (n = 4).